Company Search:
Advanced Search
Sponsored Links
Raqualia Pharma Incorporated Company Snapshot
Raqualia Pharma Incorporated operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Raqualia Pharma Incorporated with three other companies in this sector in Japan: Gene Techno Science Co Ltd (2017 sales of 1.09 billion Japanese Yen [US$9.87 million] ), PhoenixBio Co Ltd (1.23 billion Japanese Yen [US$11.13 million] ), and Medinet Co., Ltd. (1.70 billion Japanese Yen [US$15.44 million] of which 100% was cell processing).

Sales Analysis. During the year ended December of 2017, sales at Raqualia Pharma Incorporated were ¥1.42 billion (US$12.86 million). This is an increase of 101.2% versus 2016, when the company's sales were ¥705.24 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Raqualia Pharma Incorporated
  Stock Performance Chart for Raqualia Pharma Incorporated
  Stock Data: Recent Stock Performance:
  Current Price (5/18/2018): 1,448.00
(Figures in Japanese Yen)
1 Week -5.6%   13 Weeks -10.5%  
4 Weeks -14.4%   52 Weeks 78.8%  
Raqualia Pharma Incorporated Key Data:
  Ticker: 4579 Country: Japan
  Exchanges: TYO JSQ Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 1,419,195,000
(Year Ending Jan 2018).
Employees: 60
  Currency: Japanese Yen Market Cap: 29,473,961,808
  Fiscal Yr Ends: December Shares Outstanding: 20,354,946
  Share Type: Ordinary Closely Held Shares: 4,098,500
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.